
    
      -  The dose of bevacizumab and radiation therapy will be the same for all participants
           throughout the study.

        -  Bevacizumab will be given as an intravenous infusion every 2 weeks for a total of 4
           doses.

        -  Radiation therapy will begin 2 weeks after the first bevacizumab infusion and will be
           delivered 5 days per week over a period of 6 weeks. This is done as an outpatient
           procedure. Each 2 week period will be considered a separate treatment cycle.
           Participants will be treated with radiation therapy for a maximum of 3 cycles (6 weeks).

        -  A surgeon will evaluate the participants tumor by radiologic studies before study
           treatment to determine if surgical removal is possible. After the completion of study
           treatment, a surgeon will repeat the evaluation of the tumor. Surgery will performed 6-7
           weeks after the completion of radiation therapy.
    
  